Q-linea AB (OSTO:QLINEA) Net Change in Cash : kr9.02 Mil (TTM As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Q-linea AB Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Q-linea AB's Net Change in Cash for the three months ended in Dec. 2023 was kr26.95 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 was kr9.02 Mil.

Q-linea AB Net Change in Cash Historical Data

The historical data trend for Q-linea AB's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Q-linea AB Net Change in Cash Chart

Q-linea AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

-328.47

-15.82

4.94

57.79

9.02

Q-linea AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Change in Cash	Get a 7-Day Free Trial															44.02	-52.32	4.47	29.91	26.95

Q-linea AB Net Change in Cash Calculation

Q-linea AB's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-228.521	+	-7.766	+	245.407	+	-0.103
	=	9.02

Q-linea AB's Net Change in Cash for the quarter that ended in Dec. 2023

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -48.19 + 77.264 + -1.899 + -0.225

= 26.95

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr9.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Q-linea AB Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Q-linea AB's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Q-linea AB (OSTO:QLINEA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Q-linea AB (OSTO:QLINEA) » Definitions » Net Change in Cash

Comparable Companies

XSAT:BPCINS OSTO:ORTI A OSTO:IZAFE B NGM:PRLD XSAT:BIBB XSAT:MEDIMI OSTO:BIOS XSAT:ODIN XSAT:AUDNTS OSTO:S2M ISRG XPAR:EL BDX XSWX:ALC TSE:7741 WST OCSE:COLO B RMD TSE:4543 XSWX:STMN

Traded in Other Exchanges

3F8:Germany

Address

Dag Hammarskjolds vag 52 A, Uppsala, SWE, SE-752 37

Website

https://www.qlinea.com

Q-linea AB is a company that develops solutions for improved infectious disease diagnostics. It focuses on developing instruments and consumables that benefit patients, healthcare providers, and society. It develops and delivers solutions for healthcare providers, enabling them to diagnose and treat infectious diseases in the shortest possible time. The company's product, ASTar, is a fully automated instrument (AST, antibiotic susceptibility testing), which produces a sensitivity profile from a positive blood culture.

Q-linea AB (OSTO:QLINEA) Headlines

No Headlines